Stock vs Stock Comparison

Amgen Inc. vs Absci Corporation

AMGN wins the Tale of the Tape 7–2.

AMGN$338.22
ABSI$5.94

🏆 Tale of the Tape

72
AMGNABSI
21.0%Profitability (Net Margin)-4113.7%
23.4xValuation (P/E)
14.2%Efficiency (ROIC)-46.9%
7/9Health (Piotroski F)2/9
1.9Safety (Altman Z)5.1
10.0%Growth (Rev YoY)-38.2%
0.73Risk (Sharpe 1Y)0.56
9.46xBalance Sheet (D/E)0.14x
3.52%FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.194
252-Day Correlation
0.179
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricAMGNABSI
Market Cap$181.8B$1.1B
P/E Ratio23.4x
Forward P/E14.3x-10.6x
P/B19.78x6.10x
Dividend Yield2.99%
Beta0.432.38

Quantitative Metrics

MetricAMGNABSI
DCF Fair Value$264.36
DCF Upside-24.4%
Piotroski F7/92/9
Altman Z1.885.11
Beneish M-2.26
FCF Yield3.52%-21.57%
Net Debt/EBITDA2.4x
ROIC14.2%-46.9%
WACC7.1%
ROIC – WACC7.1pp
Gross Margin67.3%
Net Margin21.0%-4113.7%
Rev Growth YoY10.0%-38.2%
Sharpe (1Y)0.730.56
Max Drawdown 3Y-66.1%
FCF Payout Ratio63%

AMGN Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

AMGN found in:

IBB7.46%
DIA4.13%
SCHD3.93%
IYH3.41%
XLV3.39%
VHT3.02%
MOAT1.45%
XBI1.03%
QQQ0.97%
MGV0.93%
VIG0.84%
VTV0.73%
VYM0.71%
SCHV0.70%
IWF0.50%
VONG0.44%
ESGV0.38%
SPYG0.35%
SCHX0.34%
SCHB0.31%
IVV0.30%
VOO0.30%
SPY0.28%
VONE0.28%
VTI0.27%
SPLG0.27%
ITOT0.27%
SPTM0.26%
VFVA0.25%
URTH0.24%
RSP0.21%
SPYV0.20%
ACWI0.19%
VFMO0.18%
QUS0.17%
IWD0.16%
VT0.16%
VONV0.15%
ONEO0.09%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

AMGN vs ABSI: Head-to-Head Analysis

Amgen Inc. (AMGN) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, AMGN leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, AMGN generates a return on invested capital (ROIC) of 14.2% compared to ABSI's -46.9%. This suggests AMGN is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between AMGN and ABSI is 0.194, indicating low correlation, making them an effective diversification pair in a portfolio context.

AMGN appears in 39 ETFs tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, AMGN or ABSI?

Our quantitative analysis compares AMGN and ABSI across nine fundamental dimensions. AMGN wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are AMGN and ABSI correlated?

The 252-day correlation between AMGN and ABSI is 0.194. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.